Antimicrobiens

Inhibitor of cell wall biogenesis; glycopeptide antibiotic

Selective and potent inhibitor of sialidases (neuraminidases) in influenza A and B viruses. The compound binds tightly to the viral neuraminidase active site in late stages of viral life-cycle. It inhibits shedding sialic acids from host cell surface glycans, which interact with viral hemagglutinin, and consequently prevents release of new viral particles from the host cell surface.

Levofloxacin Hemihydrate is a fluoroquinolone antibiotic with a mode of action that inhibits bacterial DNA gyrase and topoisomerase IV. It is used for treating bacterial infections, similar to its anhydrous form.

Cefuroxime sodium is a sodium salt form of cefuroxime with similar action and applications as cefuroxime.

Herbicidin C is an antibiotic, which is derived from a microbial source, specifically from certain strains of actinobacteria. This compound functions as an inhibitor, interfering with specific metabolic pathways within target organisms. Its mode of action involves disrupting the synthesis of critical proteins, which are essential for cell survival and growth.

Treatment for leishmaniasis

Inhibitor of protein synthesis; macrolide class

Nadifloxacin is a fluoroquinolone antibiotic with action on bacterial DNA gyrase to inhibit DNA synthesis and is used for treating acne vulgaris and bacterial skin infections.

Non-nucleoside reverse transcriptase inhibitor; antiviral agent against HIV

Ethambutol 2HCl is a bacteriostatic antimycobacterial agent with action on arabinosyl transferases to inhibit cell wall synthesis and is used for treating tuberculosis in combination with other antibiotics.

Ritonavir is a HIV protease inhibitor. It has an anti-retroviral activity as it inhibits the protease enzymes specific of both HIV-1 and HIV-2 and has been shown to be effective in controlling virus replication in humans and animals. Ritonavir works by preventing the HIV viral protease enzyme from cleaving the structural and replicative proteins produced by HIV genes such as gag and pol.

Tenofovir is an acyclic nucleoside phosphonate that exhibits anti-viral properties through its inhibition of reverse transcriptases. In particular, Tenofovir is a potent inhibitor of Human Immunodeficiency Virus (HIV) and chronic Hepatitis B Virus (HBV) reverse transcriptases, thus preventing the replication of genetic viral material. This property is beneficial in virus research areas and developing antiviral treatments. Once inside the body tenofovir is metabolized into its active form, tenofovir diphosphate, by the lysosomal protease cathepsin A, nucleotide kinases and adenylate kinases. 
Tenofovir is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready to use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

Inhibitor of DNA replication; inhibitor of theophylline and caffeine metabolism

Griseofulvin is an antifungal drug used to treat several types of dermatophytosis (ringworm). This includes fungal infections of the nails, scalp and the skin when antifungal creams have not worked. It is suggested that it prevents nuclear acid production and fungal cell mitosis. Additionally, through binding to alpha and beta tubulin, it interferes with the function of the spindle and cytoplasmic microtubules.

Moxalactam Sodium Salt (Mixture of diastereomers) is an oxacephem antibiotic with action on bacterial cell wall synthesis and is used for treating infections caused by gram-negative bacteria like Escherichia coli and Pseudomonas aeruginosa

GS 5734, also known as remdesivir is a nucleoside prodrug with broad spectrum antiviral activity against RNA viruses. As remdesivir / GS 5734 is a prodrug, it requires to be triphosphorylated by cellular kinases in order to compete with ATP for incorporation in newly replicated viral RNA. A major benefit of remdesivir in comparison with other antiviral nucleoside analogs is its resistance to proofreading exonucleases, which occur in coronaviruses. This means remdesivir can overcome the repair mechanism and preserve its antiviral activity. Remdesivir was reported to have a therapeutic as well as prophylactic efficacy in a mouse model infected with SARS-CoV-1.